CIK 0001427570
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Vyome Holdings, Inc
Sign in to watch- Ticker
- HIND
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 949-429-6680
- Business address
- 1001 CALLE AMANECER, SAN CLEMENTE, CA, 92673
- Former names
- ReShape Lifesciences Inc., OBALON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 1 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-09-16 | DITTAMORE RAYMOND V Director | Grant or award · Stock Option | +27,250 | 27,250 | ||
| 2020-09-16 | DITTAMORE RAYMOND V Director | Grant or award · Stock Option (Right to Buy) | +27,250 | 27,250 | ||
| 2019-07-23 | DITTAMORE RAYMOND V Director | Grant or award | +78,125 | 105,597 | ||
| 2018-08-23 | DITTAMORE RAYMOND V Director | Grant or award | +27,472 | $1.82 | $50K | 27,472 |
| 2018-06-13 | DITTAMORE RAYMOND V Director | Grant or award · Stock Option (Right to Buy) | +81,774 | 81,774 | ||
| 2017-06-06 | DITTAMORE RAYMOND V Director | Grant or award · Stock Option (Right to Buy) | +36,554 | 36,554 | ||
| 2017-05-09 | DITTAMORE RAYMOND V Director | Grant or award · Stock Option (Right to Buy) | +21,000 | 21,000 | ||
| 2016-11-09 | DITTAMORE RAYMOND V Director | Grant or award · Stock Option (right to buy) | +20,638 | 20,638 |
Page 1 of 1 · 8 trades